Clinical Trial Update: The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating how pregnancy affects the pharmacokinetics of Kaletra (lopinavir/ritonavir) tablets in individuals with HIV. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Pregnancy, HIV | Phase 1 | Status: COMPLETED